Eli Lilly stock jumps 8% after Alzheimer’s treatment slows disease progression in major trial By: MarketWatch May 03, 2023 at 07:16 AM EDT After one year, nearly half of trial's participants showed no disease progression, says Lilly. Read More >> Related Stocks: Biogen Idec Eli Lilly
